FDA Drug/Biologics Approval BLA 761105 S-010, RISANKIZUMAB-RZAA

FDA Drug/Biologics Approval BLA 761105 S-010, RISANKIZUMAB-RZAA

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 761105 S-010
Company: ABBVIE INC
Drug Name: SKYRIZI
Active Ingredients: RISANKIZUMAB-RZAA
Strength: 150MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 04/23/2019
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details